{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T13:51:37Z","timestamp":1696600297342},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.thromres.2011.01.010","type":"journal-article","created":{"date-parts":[[2011,3,11]],"date-time":"2011-03-11T10:59:41Z","timestamp":1299841181000},"page":"8-13","source":"Crossref","is-referenced-by-count":8,"title":["Induced human pluripotent stem cells and advanced therapies"],"prefix":"10.1016","volume":"128","author":[{"given":"A.","family":"Liras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.01.010_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.stem.2007.05.012","article-title":"Strategies and new developments in the generation of patient-specific pluripotent stem cells","volume":"1","author":"Yamanaka","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.thromres.2011.01.010_bb0010","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2011.01.010_bb0015","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.thromres.2011.01.010_bb0020","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1172482","article-title":"Human induced pluripotent stem cells free of vector and transgene sequences","volume":"324","author":"Yu","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.thromres.2011.01.010_bb0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nature06534","article-title":"Reprogramming of human somatic cells to pluripotency with defined factors","volume":"451","author":"Park","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2011.01.010_bb0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nprot.2009.231","article-title":"Generation of mouse-induced pluripotent stem cells with plasmid vectors","volume":"5","author":"Okita","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.thromres.2011.01.010_bb0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature07864","article-title":"Virus-free induction of pluripotency and subsequent excision of reprogramming factors","volume":"458","author":"Kaji","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2011.01.010_bb0040","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07863","article-title":"PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells","volume":"458","author":"Woltjen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2011.01.010_bb0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.stem.2009.04.005","article-title":"Generation of induced pluripotent stem cells using recombinant proteins","volume":"4","author":"Zhou","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.thromres.2011.01.010_bb0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nmeth.1393","article-title":"A chemical platform for improved induction of human iPSCs","volume":"6","author":"Lin","year":"2009","journal-title":"Nat Methods"},{"key":"10.1016\/j.thromres.2011.01.010_bb0055","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1073\/pnas.0711983105","article-title":"Generation of human induced pluripotent stem cells from dermal fibroblasts","volume":"105","author":"Lowry","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.thromres.2011.01.010_bb0060","series-title":"White paper: The President's Council on Bioethics. Washington, D.C","article-title":"Alternative sources of human pluripotent stem cells","year":"2005"},{"key":"10.1016\/j.thromres.2011.01.010_bb0065","series-title":"National Research Council and Institute of Medicine","article-title":"2008 Amendments to the National Academies\u2019 guidelines for human embryonic stem cell research","year":"2008"},{"key":"10.1016\/j.thromres.2011.01.010_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.stem.2010.07.017","article-title":"Identification and classification of chromosomal aberrations in human induced pluripotent stem cells","volume":"7","author":"Mayshar","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.thromres.2011.01.010_bb0075","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1515\/BC.2009.103","article-title":"Induced human pluripotent stem cells: promises and open questions","volume":"390","author":"Rolletschek","year":"2009","journal-title":"Biol Chem"},{"key":"10.1016\/j.thromres.2011.01.010_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molmed.2008.12.003","article-title":"Induced pluripotent stem cells: current progress and potential for regenerative medicine","volume":"15","author":"Amabile","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.thromres.2011.01.010_bb0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1242\/dev.020867","article-title":"Epigenetic reprogramming and induced pluripotency","volume":"136","author":"Hochedlinger","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.thromres.2011.01.010_bb0090","doi-asserted-by":"crossref","first-page":"31601","DOI":"10.1074\/jbc.M806597200","article-title":"Generation of insulin-secreting islet-like clusters from human skin fibroblasts","volume":"283","author":"Tateishi","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2011.01.010_bb0095","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.thromres.2011.01.010_bb0100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2011.01.010_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2011.01.010_bb0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/scd.2007.0280","article-title":"In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes","volume":"18","author":"Caspi","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.thromres.2011.01.010_bb0115","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.thromres.2011.01.010_bb0120","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1152092","article-title":"Treatment of sickle cell anemia mouse model with iPSCs cells generated from autologous skin","volume":"318","author":"Hanna","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.thromres.2011.01.010_bb0125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCULATIONAHA.108.778795","article-title":"Generation of functional murine cardiac myocytes from induced pluripotent stem cells","volume":"118","author":"Mauritz","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.01.010_bb0130","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.thromres.2011.01.010_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2217\/rme.09.20","article-title":"Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycle","volume":"4","author":"Mason","year":"2009","journal-title":"Regen Med"},{"key":"10.1016\/j.thromres.2011.01.010_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2217\/rme.09.16","article-title":"Induced pluripotent stem cells: reprogrammed without a trace","volume":"4","author":"Nelson","year":"2009","journal-title":"Regen Med"},{"key":"10.1016\/j.thromres.2011.01.010_bb0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ilar.50.2.144","article-title":"Protein replacement therapy and gene transfer in canine models of haemophilia A, haemophilia B, von willebrand disease, and factor VII deficiency","volume":"50","author":"Nichols","year":"2009","journal-title":"ILAR J"},{"key":"10.1016\/j.thromres.2011.01.010_bb0150","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1182\/blood-2007-11-078121","article-title":"Development of gene therapy for blood disorders","volume":"111","author":"Nienhuis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.01.010_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2516.2001.00554.x","article-title":"Gene therapy for haemophilia: The end of a \u201croyal pathology\u201d in the third millennium?","volume":"7","author":"Liras","year":"2001","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2011.01.010_bb0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-2516.2009.02010.x","article-title":"Gene therapy for haemophilia\u2026yes, but\u2026with non-viral vectors?","volume":"15","author":"Liras","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2011.01.010_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0029-1214151","article-title":"Gene therapy for hemophilia: clinical trials and technical tribulations","volume":"35","author":"Viiala","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2011.01.010_bb0170","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1182\/blood-2007-03-078493","article-title":"A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice","volume":"110","author":"Brown","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.01.010_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3349\/ymj.2010.51.1.52","article-title":"Delivery of factor VIII gene into skeletal muscle cells using lentiviral vector","volume":"51","author":"Jeon","year":"2010","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.thromres.2011.01.010_bb0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1566523054065048","article-title":"AAV-mediated gene transfer for treatment of hemophilia","volume":"5","author":"Wang","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.thromres.2011.01.010_bb0185","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1182\/blood-2009-12-261156","article-title":"Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B","volume":"115","author":"Arruda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.01.010_bb0190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/hum.2007.0182","article-title":"Complete correction of hemophilia A with adeno-associated viral vectors containing a full-size expression cassette","volume":"19","author":"Lu","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.thromres.2011.01.010_bb0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/hum.2009.100","article-title":"Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses","volume":"21","author":"Jayandharan","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.thromres.2011.01.010_bb0200","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/mt.2010.73","article-title":"Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs","volume":"18","author":"Haurigot","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.thromres.2011.01.010_bb0205","doi-asserted-by":"crossref","first-page":"6114","DOI":"10.1182\/blood-2010-06-293308","article-title":"In vivo efficacy of platelet-delivered, high specific activity factor VIII variants","volume":"116","author":"Greene","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.01.010_bb0210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1538-7836.2007.02346.x","article-title":"Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A","volume":"5","author":"Shi","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.01.010_bb0215","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1182\/blood-2009-11-255612","article-title":"Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.01.010_bb0220","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.0409249102","article-title":"Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy","volume":"102","author":"Xu","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.thromres.2011.01.010_bb0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.thromres.2006.09.010","article-title":"Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice","volume":"120","author":"Xu","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.01.010_bb0230","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1182\/blood-2004-07-2648","article-title":"Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial","volume":"105","author":"Schmidt","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.01.010_bb0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.01.010_bb0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.01.010_bb0245","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jgm.1442","article-title":"Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A","volume":"12","author":"Ide","year":"2010","journal-title":"J Gene Med"},{"key":"10.1016\/j.thromres.2011.01.010_bb0250","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/mt.2010.61","article-title":"Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells","volume":"18","author":"Sivalingam","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.thromres.2011.01.010_bb0255","doi-asserted-by":"crossref","first-page":"19075","DOI":"10.1073\/pnas.0607012103","article-title":"Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation","volume":"103","author":"Aronovich","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.thromres.2011.01.010_bb0260","first-page":"935","article-title":"Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice","volume":"118","author":"Follenzi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.thromres.2011.01.010_bb0265","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1073\/pnas.0812090106","article-title":"Phenotypic correction of murine hemophilia A using an iPSCs cell-based therapy","volume":"106","author":"Xu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.thromres.2011.01.010_bb0270","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2009-02-202788","article-title":"The therapeutic effect of bone marrow\u2013derived liver cells in the phenotypic correction of murine hemophilia A","volume":"114","author":"Yadav","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2011.01.010_bb0275","first-page":"29","article-title":"Induced pluripotent stem cells: advances to applications","volume":"3","author":"Nelson","year":"2010","journal-title":"Stem Cells Cloning Adv Appl"},{"key":"10.1016\/j.thromres.2011.01.010_bb0280","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MOH.0b013e328339f2ee","article-title":"Evolution of induced pluripotent stem cell technology","volume":"17","author":"Zhou","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.thromres.2011.01.010_bb0285","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05213.x","article-title":"iPS cell technology in regenerative medicine","volume":"1192","author":"Lengner","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.thromres.2011.01.010_bb0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/11532270-000000000-00000","article-title":"Pluripotent human stem cells: A novel tool in drug discovery","volume":"24","author":"Phillips","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.thromres.2011.01.010_bb0295","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3324\/haematol.2010.023556","article-title":"Red blood cells generation from human induced pluripotent stem cells: perspectives for transfusion medicine","volume":"95","author":"Lapillonne","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2011.01.010_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biotechadv.2010.07.005","article-title":"Gene therapy, gene targeting and induced pluripotent stem cells: Applications in monogenic disease treatment","volume":"29","author":"Wong","year":"2011","journal-title":"Biotechnol Adv"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T02:51:05Z","timestamp":1543891865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0049384811000600"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.01.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}